Infliximab is a humanized antibody against tumor necrosis factor α TNF-α) that is used in the treatment of Crohn’s disease and rheumatoid arthritis.

[accordions]
[accordion title= “Chemical Properties“]

[/accordion]

[accordions]
[accordion title= “References and Literature“]

1. Dahlén R, et al. Infliximab inhibits activation and effector functions of peripheral blood T cells in vitro from patients with clinically active ulcerative colitis.Scand J Immunol. 2013 Sep;78(3):275-84.

[/accordion]